EASOobesity

EASOobesity EASO represents 36 European nations dedicated to understanding and addressing obesity.

Are you following the EASO Vimeo Channel?Recent Videos Added:✔️Psychology, Behaviour and Mental Health Working Group✔️ C...
28/12/2025

Are you following the EASO Vimeo Channel?

Recent Videos Added:
✔️Psychology, Behaviour and Mental Health Working Group
✔️ Childhood Obesity Working Group
✔️ Introducing the EASO COMs Working Group

Watch over 40 videos here: https://vimeo.com/easo

EASOobesity Early Career Network

Have you read our recent blogs on the  website?    Get caught up on EASO News with our recent bulletin.➡️ https://conta....
27/12/2025

Have you read our recent blogs on the website?

Get caught up on EASO News with our recent bulletin.

➡️ https://conta.cc/4oACMii

Happy Holidays!
24/12/2025

Happy Holidays!

🗓️ Save the date for  📍Barcelona, Spain, 10-12 June 2026The conference theme focuses on turning health strategies into c...
23/12/2025

🗓️ Save the date for
📍Barcelona, Spain, 10-12 June 2026

The conference theme focuses on turning health strategies into concrete actions to ensure systems are ready for tomorrow’s challenges and opportunities.

Learn more: https://ehmaconference.org

22/12/2025

2025 has been a year of great change and opportunity. EASO's progress is a testament to our shared commitment to advancing research, improving education, clinical care, and advocating for policies that support health & well-being in our communities and worldwide.
EASOobesity Early Career Network

 project results and key findings.Higher ADHD genetic risk was linked to an increased risk of conditions like heart fail...
21/12/2025

project results and key findings.

Higher ADHD genetic risk was linked to an increased risk of conditions like heart failure, vascular disease, obesity, type 1 diabetes, rheumatoid arthritis, and migraines.

Learn more: https://timespan.eu

Insights from the OECD report: The State of Cardiovascular Health in the European Union  ✔️Cardiovascular disease (CVD) ...
20/12/2025

Insights from the OECD report: The State of Cardiovascular Health in the European Union

✔️Cardiovascular disease (CVD) remains the leading cause of death and disability in the European Union. The OECD analysis shows that most of the CVD burden is driven by modifiable risk, with metabolic risks playing a dominant role.

Key Policy Implications

✔️ Recognise obesity as a chronic disease and a central, modifiable driver of cardiovascular diseases
✔️ Integrate obesity management into national and EU-level cardiovascular health strategies
✔️ Strengthen primary care systems for early identification and long-term management of obesity and cardio/metabolic risk
✔️ Promote integrated care models with joint health checks which will help address identified metabolic and cardiovascular conditions
✔️ Ensure equitable access to effective obesity and cardiovascular care to reduce health inequalities

Read the abstract and executive summary here: https://easo.org/obesity-at-the-centre-of-cardiovascular-disease-prevention-and-care/

Looking forward to the Global Exposome Summit ( https://www.globalexposomesummit.org) 27-29 April 2026 in Sitges, Spain....
19/12/2025

Looking forward to the Global Exposome Summit ( https://www.globalexposomesummit.org) 27-29 April 2026 in Sitges, Spain. 🇪🇸

The deadline for abstracts submission has been extended until the 6th January 2026

The 2025 COMs Summit in Paris, held in collaboration with AFERO and the French Consultation and Coordination Group of Sp...
18/12/2025

The 2025 COMs Summit in Paris, held in collaboration with AFERO and the French Consultation and Coordination Group of Specialised Obesity Centres (GCC CSO), highlighted the growing strategic importance of the COMs network, which now includes over 220 centres across 29 countries, caring for more than 400,000 patients each year

Scientific Programme Highlights

✔️ Patient perspectives
✔️ Clinical evaluation within COMs and
✔️ Use of the EASO Framework for diagnosis, staging and management of obesity
✔️ Application of the grade-based pharmacological treatment algorithm
✔️ Outcomes of metabolic and bariatric surgery and their integration with ongoing medical treatment
✔️ Developments in precision medicine, hospital-community collaboration, and industry-led innovation
✔️ Updates on MASLD, pharmacological treatment, and body composition assessment
✔️ In the adult track: biological and clinical drivers of obesity and the management of complex cases
✔️ In the paediatric track: early-onset and monogenic obesity, readiness for pharmacotherapy, and the role of paediatric surgery, emphasising early, structured and family-centred care within specialised networks

Future Directions will include

✔️ Integrated pharmacological, surgical and behavioural care
✔️ Long-term measurement of patient-centred outcomes
✔️ Stronger links between clinical practice, research and policy

Learn more about the EASO COMs Summit and 2025 programme, here: https://easo.org/easo-coms-summit-2025-in-paris-france/

▶️ Interested in contributing to the 33rd European Congress on Obesity scientific programme?Abstract submissions and sym...
16/12/2025

▶️ Interested in contributing to the 33rd European Congress on Obesity scientific programme?

Abstract submissions and symposium suggestions for are open. Submission Deadline: Jan 11th 2026

Share your high-quality research and clinical work!

https://eco2026.org/?p=abstract-submission

Address


Alerts

Be the first to know and let us send you an email when EASOobesity posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to EASOobesity:

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

COVID-19 AND OBESITY

The EASO medical and scientific community all across Europe is intensively engaged in addressing the global COVID-19 pandemic. Our clinicians are working in the front line of care daily for patients living with obesity within emergency care systems, in coordination with other clinical colleagues across 34 countries. Our scientists are hard at work developing tools and frameworks for contributing to psychological support for clinicians and patients, developing and implementing public health strategies, providing guidance and support for whole family assistance, and development and provision of advice for children and teens.

Our role in this crisis will be crucial in the dissemination of science-based information and providing common-sense, evidence-based updates, recommendations and guidance via our website and social media, that can reach millions of people. EASO is committed to sharing only the latest well evidenced information and guidance from credible sources.

People living with the chronic disease obesity are particularly vulnerable to the effects of the novel coronavirus, and appear to have a higher rate of serious complications from the virus. It is paramount that people with obesity avoid infection. We herein recommend that people with obesity shelter at home during this time, following their national guidance for vulnerable people living with chronic disease.

Infographics developed in conjunction with our scientific and patient communities focused on energy balance; mental health; family life with children and adolescents;and indoor exercise, all helpful during COVID-19, are available for download on the EASO website.